Filippatos TD - Search Results

1

SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses.

Filippatos TD, Liontos A, Papakitsou I, Elisaf MS. Filippatos TD, et al. Postgrad Med. 2019 Mar;131(2):82-88. doi: 10.1080/00325481.2019.1581971. Postgrad Med. 2019. PMID: 30757937 Review.

2

The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

Kiortsis DN, Filippatos TD, Elisaf MS. Kiortsis DN, et al. Among authors: filippatos td. Diabetes Metab. 2005 Feb;31(1):15-22. doi: 10.1016/s1262-3636(07)70161-1. Diabetes Metab. 2005. PMID: 15803108 Review.

3

A review of the metabolic effects of sibutramine.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Filippatos TD, et al. Curr Med Res Opin. 2005 Mar;21(3):457-68. doi: 10.1185/030079905X38132. Curr Med Res Opin. 2005. PMID: 15811215 Review.

4

Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?

Milionis HJ, Gazi IF, Filippatos TD, Tzovaras V, Chasiotis G, Goudevenos J, Seferiadis K, Elisaf MS. Milionis HJ, et al. Among authors: filippatos td. Angiology. 2005 Sep-Oct;56(5):585-92. doi: 10.1177/000331970505600510. Angiology. 2005. PMID: 16193198 Clinical Trial.

5

Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.

Milionis HJ, Filippatos TD, Loukas T, Bairaktari ET, Tselepis AD, Elisaf MS. Milionis HJ, et al. Among authors: filippatos td. Atherosclerosis. 2006 Jul;187(1):170-6. doi: 10.1016/j.atherosclerosis.2005.08.036. Epub 2005 Sep 28. Atherosclerosis. 2006. PMID: 16197951

6

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.

Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD. Gazi I, et al. Clin Chem. 2005 Dec;51(12):2264-73. doi: 10.1373/clinchem.2005.058404. Epub 2005 Oct 13. Clin Chem. 2005. PMID: 16223884

7

Alterations in electrolyte equilibrium in patients with acute leukemia.

Filippatos TD, Milionis HJ, Elisaf MS. Filippatos TD, et al. Eur J Haematol. 2005 Dec;75(6):449-60. doi: 10.1111/j.1600-0609.2005.00547.x. Eur J Haematol. 2005. PMID: 16313256 Review.

8

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS. Filippatos TD, et al. Curr Med Res Opin. 2005 Dec;21(12):1997-2006. doi: 10.1185/030079905x75078. Curr Med Res Opin. 2005. PMID: 16368051 Clinical Trial.

9

LDL cholesterol estimation in patients with the metabolic syndrome.

Gazi I, Tsimihodimos V, Filippatos TD, Saougos VG, Bairaktari ET, Tselepis AD, Elisaf M. Gazi I, et al. Among authors: filippatos td. Lipids Health Dis. 2006 Apr 6;5:8. doi: 10.1186/1476-511X-5-8. Lipids Health Dis. 2006. PMID: 16600020 Free PMC article.

10

Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.

Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Gazi I, et al. Metabolism. 2006 Jul;55(7):885-91. doi: 10.1016/j.metabol.2006.02.015. Metabolism. 2006. PMID: 16784959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page